Effect of Vitamin C on Pain Reduction After an Emergency Department Visit

ConditionPain, Acute
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

About this trial

Musculoskeletal (MSK) injuries such as sprains, strains, bruises, and fractures are among the most common reasons people visit the emergency department. These injuries often cause significant pain in the first few days, making it difficult to move, work, or sleep. Usual pain medications like ibuprofen or acetaminophen can help, but they are not safe or effective for everyone. Some people cannot take them because of heart, kidney, stomach, or liver problems. Others still experience strong pain despite treatment. Because of these limits, some patients receive opioids, which can cause side effects and carry a risk of dependence. Safer and more accessible options are needed.

Vitamin C is widely known for supporting the immune system, but research suggests it may also help reduce pain and inflammation. Studies in surgical patients have shown that vitamin C can lower pain levels, reduce the need for opioids, and support healing. These effects may be linked to its antioxidant properties and its role in tissue repair. However, no study has tested whether vitamin C can help people with recent MSK injuries treated in the emergency department.

The VICAMED study aims to answer this question. Adults arriving with an MSK injury that occurred within the past 48 hours can participate if they have at least moderate pain. Participants are randomly assigned to receive either vitamin C or a placebo. The first dose is given in the emergency department, followed by twice daily capsules for three days. Pain is measured using a simple 0-100 scale, recorded in an electronic or paper diary. A follow-up on day six helps the research team understand each participant's recovery, medication use, and overall experience.

Vitamin C is inexpensive, widely available, and very safe at the doses used in this study. If it proves effective, it could offer a simple, low risk option to help patients manage pain after an MSK injury and reduce the need for opioids in emergency care.

Eligibility criteria

Qualifiers

Age ≥ 18 years old

Presenting to the ED with acute MSK pain of ≤ 48 hours duration at triage

Verbal numerical rating scale pain intensity at triage of ≥ 4 on a 0-10 scale

Triaged to the ambulatory section of the ED

Disqualifiers

Usage of Vit C supplements in the last week

Active cancer

Treated with opioids for any pain within 24 hours prior to recruitment

Treatment for chronic pain

Trial design

Treatments tested in this trial

  • Vitamin C
  • Placebo

Treatment groups

204 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Lead sponsor

Hopital de l'Enfant-Jesus

Collaborator

The Ottawa Hospital

Collaborator